Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pembrolizumab

Hypothyroidism and adrenocorticotropic hormone deficiency: case report

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Yamagata S, et al. Progression of hypopituitarism and hypothyroidism after treatment with pembrolizumab in a patient with adrenal metastasis from non-small-cell lung cancer. Internal Medicine 58: 3557-3562, No. 24, 15 Dec 2019. Available from: URL: http://doi.org/10.2169/internalmedicine.3008-19

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Pembrolizumab. Reactions Weekly 1791, 210 (2020). https://doi.org/10.1007/s40278-020-75055-5

    Download citation